K-877

pemafibrate · Kowa Company, Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for K-877, covering 2016-03-25 to 2025-10-06. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Pharmacology Study of K-877 Controlled Release Tablet [Phase 2]